[1]
Nidal Karim Al-Rahal, Oula Abdullah Najim, Ahmed Shemran Alwataify, Israa Mustafa Almusawi, Ahmed Ibrahim Shukr, Yaser Shanyor Alsalman, “Emicizumab Prophylaxis Every Four weeks among Hemophilia a with Inhibitors in Iraq, Multicenter Study”, JRTDD, vol. 5, no. 2s, pp. 477–482, Dec. 2022.